COVID-19 Impact on Global Measle Vaccine, Market Insights and Forecast to 2026
Measle Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Measle Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Measle Vaccine market is segmented into
The Measle Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Measle Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Measle Vaccine Market Share Analysis
Measle Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Measle Vaccine business, the date to enter into the Measle Vaccine market, Measle Vaccine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Measle Vaccine market is segmented into
- Inactivated Vaccine
- Attenuated Vaccine
- Hospital
- Scientific Research
- Others
The Measle Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Measle Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Measle Vaccine Market Share Analysis
Measle Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Measle Vaccine business, the date to enter into the Measle Vaccine market, Measle Vaccine product introduction, recent developments, etc.
The major vendors covered:
- Merck
- Biovac
- McKesson Medical
1 STUDY COVERAGE
1.1 Measle Vaccine Product Introduction
1.2 Market Segments
1.3 Key Measle Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Measle Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Vaccine
1.4.3 Attenuated Vaccine
1.5 Market by Application
1.5.1 Global Measle Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Measle Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Measle Vaccine Industry
1.6.1.1 Measle Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Measle Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Measle Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Measle Vaccine Market Size Estimates and Forecasts
2.1.1 Global Measle Vaccine Revenue 2015-2026
2.1.2 Global Measle Vaccine Sales 2015-2026
2.2 Measle Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Measle Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Measle Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL MEASLE VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Measle Vaccine Sales by Manufacturers
3.1.1 Measle Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Measle Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Measle Vaccine Revenue by Manufacturers
3.2.1 Measle Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Measle Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Measle Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Measle Vaccine Revenue in 2019
3.2.5 Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Measle Vaccine Price by Manufacturers
3.4 Measle Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Measle Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Measle Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Measle Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Measle Vaccine Market Size by Type (2015-2020)
4.1.1 Global Measle Vaccine Sales by Type (2015-2020)
4.1.2 Global Measle Vaccine Revenue by Type (2015-2020)
4.1.3 Measle Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Measle Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Measle Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Measle Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Measle Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Measle Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Measle Vaccine Market Size by Application (2015-2020)
5.1.1 Global Measle Vaccine Sales by Application (2015-2020)
5.1.2 Global Measle Vaccine Revenue by Application (2015-2020)
5.1.3 Measle Vaccine Price by Application (2015-2020)
5.2 Measle Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Measle Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Measle Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Measle Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Measle Vaccine by Country
6.1.1 North America Measle Vaccine Sales by Country
6.1.2 North America Measle Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Measle Vaccine Market Facts & Figures by Type
6.3 North America Measle Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Measle Vaccine by Country
7.1.1 Europe Measle Vaccine Sales by Country
7.1.2 Europe Measle Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Measle Vaccine Market Facts & Figures by Type
7.3 Europe Measle Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Measle Vaccine by Region
8.1.1 Asia Pacific Measle Vaccine Sales by Region
8.1.2 Asia Pacific Measle Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Measle Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Measle Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Measle Vaccine by Country
9.1.1 Latin America Measle Vaccine Sales by Country
9.1.2 Latin America Measle Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Measle Vaccine Market Facts & Figures by Type
9.3 Central & South America Measle Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Measle Vaccine by Country
10.1.1 Middle East and Africa Measle Vaccine Sales by Country
10.1.2 Middle East and Africa Measle Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Measle Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Measle Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Measle Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 Biovac
11.2.1 Biovac Corporation Information
11.2.2 Biovac Description, Business Overview and Total Revenue
11.2.3 Biovac Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biovac Measle Vaccine Products Offered
11.2.5 Biovac Recent Development
11.3 McKesson Medical
11.3.1 McKesson Medical Corporation Information
11.3.2 McKesson Medical Description, Business Overview and Total Revenue
11.3.3 McKesson Medical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 McKesson Medical Measle Vaccine Products Offered
11.3.5 McKesson Medical Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Measle Vaccine Products Offered
11.1.5 Merck Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Measle Vaccine Market Estimates and Projections by Region
12.1.1 Global Measle Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Measle Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Measle Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Measle Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Measle Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Measle Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Measle Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Measle Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Measle Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Measle Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Measle Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Measle Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Measle Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Measle Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Measle Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Measle Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Measle Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Measle Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Measle Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Measle Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Measle Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Measle Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Measle Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Measle Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Measle Vaccine Product Introduction
1.2 Market Segments
1.3 Key Measle Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Measle Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Vaccine
1.4.3 Attenuated Vaccine
1.5 Market by Application
1.5.1 Global Measle Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Measle Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Measle Vaccine Industry
1.6.1.1 Measle Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Measle Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Measle Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Measle Vaccine Market Size Estimates and Forecasts
2.1.1 Global Measle Vaccine Revenue 2015-2026
2.1.2 Global Measle Vaccine Sales 2015-2026
2.2 Measle Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Measle Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Measle Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL MEASLE VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Measle Vaccine Sales by Manufacturers
3.1.1 Measle Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Measle Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Measle Vaccine Revenue by Manufacturers
3.2.1 Measle Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Measle Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Measle Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Measle Vaccine Revenue in 2019
3.2.5 Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Measle Vaccine Price by Manufacturers
3.4 Measle Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Measle Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Measle Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Measle Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Measle Vaccine Market Size by Type (2015-2020)
4.1.1 Global Measle Vaccine Sales by Type (2015-2020)
4.1.2 Global Measle Vaccine Revenue by Type (2015-2020)
4.1.3 Measle Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Measle Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Measle Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Measle Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Measle Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Measle Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Measle Vaccine Market Size by Application (2015-2020)
5.1.1 Global Measle Vaccine Sales by Application (2015-2020)
5.1.2 Global Measle Vaccine Revenue by Application (2015-2020)
5.1.3 Measle Vaccine Price by Application (2015-2020)
5.2 Measle Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Measle Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Measle Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Measle Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Measle Vaccine by Country
6.1.1 North America Measle Vaccine Sales by Country
6.1.2 North America Measle Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Measle Vaccine Market Facts & Figures by Type
6.3 North America Measle Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Measle Vaccine by Country
7.1.1 Europe Measle Vaccine Sales by Country
7.1.2 Europe Measle Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Measle Vaccine Market Facts & Figures by Type
7.3 Europe Measle Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Measle Vaccine by Region
8.1.1 Asia Pacific Measle Vaccine Sales by Region
8.1.2 Asia Pacific Measle Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Measle Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Measle Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Measle Vaccine by Country
9.1.1 Latin America Measle Vaccine Sales by Country
9.1.2 Latin America Measle Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Measle Vaccine Market Facts & Figures by Type
9.3 Central & South America Measle Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Measle Vaccine by Country
10.1.1 Middle East and Africa Measle Vaccine Sales by Country
10.1.2 Middle East and Africa Measle Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Measle Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Measle Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Measle Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 Biovac
11.2.1 Biovac Corporation Information
11.2.2 Biovac Description, Business Overview and Total Revenue
11.2.3 Biovac Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biovac Measle Vaccine Products Offered
11.2.5 Biovac Recent Development
11.3 McKesson Medical
11.3.1 McKesson Medical Corporation Information
11.3.2 McKesson Medical Description, Business Overview and Total Revenue
11.3.3 McKesson Medical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 McKesson Medical Measle Vaccine Products Offered
11.3.5 McKesson Medical Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Measle Vaccine Products Offered
11.1.5 Merck Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Measle Vaccine Market Estimates and Projections by Region
12.1.1 Global Measle Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Measle Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Measle Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Measle Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Measle Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Measle Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Measle Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Measle Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Measle Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Measle Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Measle Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Measle Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Measle Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Measle Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Measle Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Measle Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Measle Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Measle Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Measle Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Measle Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Measle Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Measle Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Measle Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Measle Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Measle Vaccine Market Segments
Table 2. Ranking of Global Top Measle Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Measle Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Inactivated Vaccine
Table 5. Major Manufacturers of Attenuated Vaccine
Table 6. COVID-19 Impact Global Market: (Four Measle Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Measle Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Measle Vaccine Players to Combat Covid-19 Impact
Table 11. Global Measle Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Measle Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Measle Vaccine Sales by Regions 2015-2020 (K Units)
Table 14. Global Measle Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Measle Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Measle Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Measle Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Measle Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Measle Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measle Vaccine as of 2019)
Table 20. Measle Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Measle Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Measle Vaccine Price (2015-2020) (USD/Unit)
Table 23. Measle Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Measle Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Measle Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 28. Global Measle Vaccine Sales Share by Type (2015-2020)
Table 29. Global Measle Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Measle Vaccine Revenue Share by Type (2015-2020)
Table 31. Measle Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 33. Global Measle Vaccine Sales Share by Application (2015-2020)
Table 34. North America Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 35. North America Measle Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 39. North America Measle Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 41. North America Measle Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 43. Europe Measle Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 47. Europe Measle Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 49. Europe Measle Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Measle Vaccine Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Measle Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Measle Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Measle Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Measle Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Measle Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 59. Latin America Measle Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 63. Latin America Measle Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 65. Latin America Measle Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Measle Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Measle Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Measle Vaccine Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Measle Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Biovac Corporation Information
Table 80. Biovac Description and Major Businesses
Table 81. Biovac Measle Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Biovac Product
Table 83. Biovac Recent Development
Table 84. McKesson Medical Corporation Information
Table 85. McKesson Medical Description and Major Businesses
Table 86. McKesson Medical Measle Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. McKesson Medical Product
Table 88. McKesson Medical Recent Development
Table 89. Global Measle Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 90. Global Measle Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Measle Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Measle Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 94. North America: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 96. Europe: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Measle Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 98. Asia Pacific: Measle Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 100. Latin America: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 102. Middle East and Africa: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Measle Vaccine Players
Table 107. Measle Vaccine Customers List
Table 108. Measle Vaccine Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 1. Measle Vaccine Market Segments
Table 2. Ranking of Global Top Measle Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Measle Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Inactivated Vaccine
Table 5. Major Manufacturers of Attenuated Vaccine
Table 6. COVID-19 Impact Global Market: (Four Measle Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Measle Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Measle Vaccine Players to Combat Covid-19 Impact
Table 11. Global Measle Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Measle Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Measle Vaccine Sales by Regions 2015-2020 (K Units)
Table 14. Global Measle Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Measle Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Measle Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Measle Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Measle Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Measle Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measle Vaccine as of 2019)
Table 20. Measle Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Measle Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Measle Vaccine Price (2015-2020) (USD/Unit)
Table 23. Measle Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Measle Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Measle Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 28. Global Measle Vaccine Sales Share by Type (2015-2020)
Table 29. Global Measle Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Measle Vaccine Revenue Share by Type (2015-2020)
Table 31. Measle Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 33. Global Measle Vaccine Sales Share by Application (2015-2020)
Table 34. North America Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 35. North America Measle Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 39. North America Measle Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 41. North America Measle Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 43. Europe Measle Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 47. Europe Measle Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 49. Europe Measle Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Measle Vaccine Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Measle Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Measle Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Measle Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Measle Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Measle Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 59. Latin America Measle Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 63. Latin America Measle Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 65. Latin America Measle Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Measle Vaccine Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Measle Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Measle Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Measle Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Measle Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Measle Vaccine Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Measle Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Biovac Corporation Information
Table 80. Biovac Description and Major Businesses
Table 81. Biovac Measle Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Biovac Product
Table 83. Biovac Recent Development
Table 84. McKesson Medical Corporation Information
Table 85. McKesson Medical Description and Major Businesses
Table 86. McKesson Medical Measle Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. McKesson Medical Product
Table 88. McKesson Medical Recent Development
Table 89. Global Measle Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 90. Global Measle Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Measle Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Measle Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 94. North America: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 96. Europe: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Measle Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 98. Asia Pacific: Measle Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 100. Latin America: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Measle Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 102. Middle East and Africa: Measle Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Measle Vaccine Players
Table 107. Measle Vaccine Customers List
Table 108. Measle Vaccine Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Measle Vaccine Product Picture
Figure 2. Global Measle Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Global Measle Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Measle Vaccine Report Years Considered
Figure 10. Global Measle Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Measle Vaccine Sales 2015-2026 (K Units)
Figure 12. Global Measle Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Measle Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Measle Vaccine Sales Market Share by Region in 2019
Figure 15. Global Measle Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Measle Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Measle Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Measle Vaccine Revenue in 2019
Figure 19. Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Measle Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Measle Vaccine Sales Market Share by Type in 2019
Figure 22. Global Measle Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Measle Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Measle Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Measle Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Measle Vaccine Sales Market Share by Application in 2019
Figure 27. Global Measle Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Measle Vaccine Revenue Market Share by Application in 2019
Figure 29. North America Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Measle Vaccine Sales Market Share by Country in 2019
Figure 32. North America Measle Vaccine Revenue Market Share by Country in 2019
Figure 33. U.S. Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Measle Vaccine Market Share by Type in 2019
Figure 38. North America Measle Vaccine Market Share by Application in 2019
Figure 39. Europe Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Measle Vaccine Sales Market Share by Country in 2019
Figure 42. Europe Measle Vaccine Revenue Market Share by Country in 2019
Figure 43. Germany Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Measle Vaccine Market Share by Type in 2019
Figure 54. Europe Measle Vaccine Market Share by Application in 2019
Figure 55. Asia Pacific Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Measle Vaccine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Measle Vaccine Revenue Market Share by Region in 2019
Figure 59. China Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Measle Vaccine Market Share by Type in 2019
Figure 82. Asia Pacific Measle Vaccine Market Share by Application in 2019
Figure 83. Latin America Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Measle Vaccine Sales Market Share by Country in 2019
Figure 86. Latin America Measle Vaccine Revenue Market Share by Country in 2019
Figure 87. Mexico Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Measle Vaccine Market Share by Type in 2019
Figure 94. Latin America Measle Vaccine Market Share by Application in 2019
Figure 95. Middle East and Africa Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Measle Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Measle Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Measle Vaccine Market Share by Type in 2019
Figure 106. Middle East and Africa Measle Vaccine Market Share by Application in 2019
Figure 107. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Biovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. McKesson Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. North America Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
Figure 1. Measle Vaccine Product Picture
Figure 2. Global Measle Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Global Measle Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Measle Vaccine Report Years Considered
Figure 10. Global Measle Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Measle Vaccine Sales 2015-2026 (K Units)
Figure 12. Global Measle Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Measle Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Measle Vaccine Sales Market Share by Region in 2019
Figure 15. Global Measle Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Measle Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Measle Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Measle Vaccine Revenue in 2019
Figure 19. Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Measle Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Measle Vaccine Sales Market Share by Type in 2019
Figure 22. Global Measle Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Measle Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Measle Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Measle Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Measle Vaccine Sales Market Share by Application in 2019
Figure 27. Global Measle Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Measle Vaccine Revenue Market Share by Application in 2019
Figure 29. North America Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Measle Vaccine Sales Market Share by Country in 2019
Figure 32. North America Measle Vaccine Revenue Market Share by Country in 2019
Figure 33. U.S. Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Measle Vaccine Market Share by Type in 2019
Figure 38. North America Measle Vaccine Market Share by Application in 2019
Figure 39. Europe Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Measle Vaccine Sales Market Share by Country in 2019
Figure 42. Europe Measle Vaccine Revenue Market Share by Country in 2019
Figure 43. Germany Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Measle Vaccine Market Share by Type in 2019
Figure 54. Europe Measle Vaccine Market Share by Application in 2019
Figure 55. Asia Pacific Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Measle Vaccine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Measle Vaccine Revenue Market Share by Region in 2019
Figure 59. China Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Measle Vaccine Market Share by Type in 2019
Figure 82. Asia Pacific Measle Vaccine Market Share by Application in 2019
Figure 83. Latin America Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Measle Vaccine Sales Market Share by Country in 2019
Figure 86. Latin America Measle Vaccine Revenue Market Share by Country in 2019
Figure 87. Mexico Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Measle Vaccine Market Share by Type in 2019
Figure 94. Latin America Measle Vaccine Market Share by Application in 2019
Figure 95. Middle East and Africa Measle Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Measle Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Measle Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Measle Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Measle Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Measle Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Measle Vaccine Market Share by Type in 2019
Figure 106. Middle East and Africa Measle Vaccine Market Share by Application in 2019
Figure 107. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Biovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. McKesson Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. North America Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Measle Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Measle Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
